Company completes Series D funding and adds two new directors to board (ANN ARBOR, Mich.) Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the completion of a Series D funding raise of $12.2 million. The company also announced the addition of two new directors to its board, positioning the […]

Life sciences executive brings proven ability to develop and drive adoption of transformational technologies SOUTH SAN FRANCISCO, Calif. – June 29, 2017 – Biodesy, Inc., the next-generation protein analysis company, today announced that Dominique Bridon, PhD, has been appointed Chief Executive Officer and a member of the board of directors, effective immediately. Dr. Bridon brings […]

Executive with Successful Entrepreneurial Track Record and Large Company Experience Elected to Support Next Phase of Akonni’s Corporate Evolution Frederick, MD — Akonni Biosystems, a molecular diagnostics (MDx) company that develops, manufactures, and intends to market advanced MDx systems, today announced the election of Mr. Brian J. Morra as the company’s Executive Chairman of the Board of […]

MILFORD, Mass.– Waters Corporation (NYSE: WAT) today announced Dr. Flemming Ornskov, Chief Executive Officer of Shire plc, has been elected as a Director of Waters® Corporation effective today. “It is an honor to welcome Flemming Ornskov to our Board of Directors,” said Christopher J. O’Connell, Waters Corporation President and CEO. “Flemming’s broad, global leadership experience in the biopharmaceutical industry will add great value […]

Dr. Ralf Hermann started work as the new General Manager Constant temperature equipment on June 1, 2017 at LAUDA, the global leader in the manufacture of Constant temperature equipment and systems. With his extensive experience and comprehensive specialized knowledge gained from many years in a managerial capacity at Eppendorf AG, as well as his PhD […]

SAN DIEGO, CA. — June 15, 2017— Molecular Assemblies Inc., a company developing a proprietary enzymatic DNA synthesis technology, today announced that it has expanded its board of directors with the appointment of Sean Freeman, NuVasive head of strategy and corporate development, to its board of directors. “Sean’s extensive business development experience in both strategic […]

SARASOTA, Fla. — Roper Technologies, Inc. (NYSE:ROP), a diversified technology company, today announced the appointment of two executives to its finance team. Zack Moxcey has been named Vice President, Investor Relations.  Mr. Moxcey joins Roper from Microsoft where he was Director, Investor Relations, focused on the Cloud & Enterprise and Applications & Services engineering groups.  […]